Cover Image
Market Research Report
Product code
998311

Global Continuous Positive Airway Pressure (CPAP) Market: Analysis and Forecast, 2020-2026

Published: | BIS Research Inc. | 235 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Continuous Positive Airway Pressure (CPAP) Market: Analysis and Forecast, 2020-2026
Published: March 24, 2021
BIS Research Inc.
Content info: 235 Pages
Delivery time: 1-2 business days
  • ALL
  • Description
  • Table of Contents
Description

Global Continuous Positive Airway Pressure Market to Reach $10,182.0 Million by 2026

Market Report Coverage - Continuous Positive Airway Pressure (CPAP)

Market Segmentation

  • End User (Hospitals and Clinics, Nursing Homes, Elderly Care Centers, and Home-Use)

Regional Segmentation

  • North America - U.S., Canada
  • EU5 - Germany, France, Italy, U.K., Spain
  • Asia-Pacific - China, Japan, India, South Korea, Rest-of-Asia-Pacific (RoAPAC)
  • Rest-of-the-World

Growth Drivers

  • Rising Number of Startups Driving Innovation
  • Increasing Prevalence of Obstructive Sleep Apnea
  • Growing Prevalence of Respiratory Diseases Among the Geriatric Population
  • Growing Prevalence of Chronic Respiratory Diseases across the Globe

Market Challenges

  • High Upfront Cost of Device
  • Side-Effects Associated with Long-Term Usage

Market Opportunities

  • Development of Smart CPAP Devices
  • Digitization of Device Training Modules to Promote Adoption

Key Companies Profiled

Airon Corporation, APEX MEDICAL CORP., Asahi Kasei Corporation, BMC Medical Co., Ltd, Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, General Electric Company, Getinge AB, Koninklijke Philips N.V., Lowenstein Medical GmbH & Co. KG, Medical Depot, Inc. dba drives DeVilbiss Healthcare LLC, Medtronic Plc, ResMed, Inc., Smiths Group plc (Smiths Medical) and VYAIRE MEDICAL, INC.

Key Questions Answered in this Report:

  • How has COVID-19 impacted the adoption of CPAP devices in the market?
  • What are the key regulations which influence the adoption of CPAP devices in the market?
  • What are some of the key brands in the global and regional CPAP market?
  • Who are the top competitors in each region?
  • What are some of the key factors influencing the growth in adopting CPAP devices across the globe?
  • How do the brands compare against each other in terms of unit shipments?
  • What are the fastest-growing countries in terms of CPAP adoption?
  • Which are the key diseases driving the adoption of CPAP devices across the world?
  • What are the key strategies being adopted by market players in the global CPAP market?
  • Who are the most common end-users of CPAP devices, and how are the end-use segment expected to grow in the future?

Key USPs of the Report

Following are some of the key contents of the report:

  • Epidemiological Landscape

This section includes exhaustive information on the epidemiology of key disease indications for the CPAP domain.

  • Patent Scenario

This section encompasses a description of the current patent landscape in the continuous positive airway pressure field.

  • Regulatory Framework

This section comprises the information on the regulatory framework for various regulatory bodies associated with granting approval to CPAP devices.

  • Impact of COVID-19

This section of the report encompasses the following:

    • Impact on CPAP Demand and Supply
    • Regional Impact
    • Future Impact (Short-, mid-, and long-term)

In addition, the report provides:

  • A detailed analysis and growth forecast (2020-2026) for different end-users
  • Recent developments and trends in the global market landscape
  • Factors promoting and inhibiting the market growth

Expert Quote

"At present, what we have is heavy demand for CPAP devices due to the emergency regulatory authorizations made by FDA to use CPAP devices during the treatment of COVID-19. Will this demand remain high in the future when the healthcare industry is normalizing? It remains to be seen. The general idea is that it will gradually reduce back to normal, the rate of which depends on the type of recovery pattern from COVID-19".

Scope of the Global CPAP Market

The purpose of the study is to enable the reader to gain a holistic view of the global CPAP market by each of the aforementioned segments.

The report constitutes an in-depth analysis of the global CPAP market, including a thorough analysis of the different end-users. The study also provides exhaustive information on disease epidemiology, competitive landscape, brand share landscape, market share of the leading players, number of CPAP units shipped, as well as other vital information with respect to the global CPAP market. The report considers CPAP device and Ventilators (offering CPAP mode) manufacturers.

Table of Contents
Product Code: BHM1045SA

Table of Contents

Executive Summary

1 Product Definition

2 Scope of Report

  • 2.1 Scope of Study
  • 2.2 Inclusion and Exclusion Criteria of the Report
    • 2.2.1 Inclusion Criteria
    • 2.2.2 Exclusion Criteria
  • 2.3 Key Questions Answered by the Research Study

3 Research Methodology

  • 3.1 Primary Data Sources
  • 3.2 Secondary Data Sources
  • 3.3 Data Source Categorization
  • 3.4 Market Estimation Model
  • 3.5 Data Validation
  • 3.6 Selection Criteria for Company Profiles
  • 3.7 Forecast, Assumptions, and Limitations

4 Impact of COVID-19 on Global Continuous Positive Airway Pressure (CPAP) Market

  • 4.1 Industry Scenario: Impact of COVID-19 on the Global CPAP Demand and Supply
  • 4.2 Regional Impact
  • 4.3 Future Perspective

5 Epidemiological Landscape

  • 5.1 Obstructive Sleep Apnea (OSA)
    • 5.1.1 Global Prevalence and Incidence
      • 5.1.1.1 North America Prevalence and Incidence
      • 5.1.1.2 EU5 Prevalence and Incidence
      • 5.1.1.3 Asia-Pacific Prevalence and Incidence
    • 5.1.2 CPAP Devices Demand
  • 5.2 Chronic Obstructive Respiratory Diseases (CORD)
    • 5.2.1 Global Prevalence and Incidence
      • 5.2.1.1 North America Prevalence and Incidence
      • 5.2.1.2 EU5 Prevalence and Incidence
      • 5.2.1.3 Asia-Pacific Prevalence and Incidence
    • 5.2.2 CPAP Devices Demand
  • 5.3 Neuromuscular Disorders
    • 5.3.1 Global Prevalence and Incidence
      • 5.3.1.1 North America Prevalence and Incidence
      • 5.3.1.2 EU5 Prevalence and Incidence
      • 5.3.1.3 Asia-Pacific Prevalence and Incidence
    • 5.3.2 CPAP Devices Demand
  • 5.4 COVID-19
    • 5.4.1 Global Prevalence and Incidence
      • 5.4.1.1 North America Prevalence and Incidence
      • 5.4.1.2 EU5 Prevalence and Incidence
      • 5.4.1.3 Asia-Pacific Prevalence and Incidence
    • 5.4.2 CPAP Devices Demand
  • 5.5 Other Conditions
    • 5.5.1 Asthma Incidence
    • 5.5.2 Asthma Prevalence
    • 5.5.3 Pneumoconiosis Incidence
    • 5.5.4 Pneumoconiosis Prevalence
    • 5.5.5 Upper Respiratory Tract Infections Incidence
    • 5.5.6 Upper Respiratory Tract Infections Prevalence
    • 5.5.7 Lower Respiratory Tract Infections Incidence
    • 5.5.8 Lower Respiratory Tract Infections Prevalence
    • 5.5.9 CPAP Devices Demand

6 Industry Analysis

  • 6.1 Industry Structure
    • 6.1.1 CPAP Systems Manufacturers
    • 6.1.2 Product Distributors / Resellers
  • 6.2 Industry Supply Chain Analysis
  • 6.3 Associations and Consortiums
  • 6.4 Regulatory Framework
    • 6.4.1 Regulations in North America
      • 6.4.1.1 Food and Drug Administration (FDA)
      • 6.4.1.2 Health Canada
    • 6.4.2 Regulations in Europe
    • 6.4.3 Regulations in Asia-Pacific
      • 6.4.3.1 National Medical Products Administration (NMPA)
      • 6.4.3.2 Pharmaceutical and Medical Device Agency (PMDA)
  • 6.5 Patent Landscape
    • 6.5.1 Patent Analysis by Country
    • 6.5.2 Patent Analysis by Quarters

7 Competitive Landscape

  • 7.1 Competitive Landscape
    • 7.1.1 Market Share Analysis
    • 7.1.2 Growth Share Matrix (2015-2019)
  • 7.2 Key Developments and Strategies
    • 7.2.1 New Offerings
    • 7.2.2 Partnerships and Alliances
    • 7.2.3 Regulatory and Legal Activities
    • 7.2.4 Mergers and Acquisitions

8 Continuous Positive Airway Pressure Market Sizing and Forecast

  • 8.1 Assumptions and Limitations
  • 8.2 Opportunity Assessment
    • 8.2.1 Opportunity Assessment
  • 8.3 Global CPAP Market Size and Growth Potential, 2015-2026
  • 8.4 Current Market Trends Analysis
  • 8.5 Market Dynamics
    • 8.5.1 Market Drivers
      • 8.5.1.1 Rising Number of Startups Driving Innovation
      • 8.5.1.2 Increasing Prevalence of Obstructive Sleep Apnea
      • 8.5.1.3 Growing Prevalence of Respiratory Diseases among the Geriatric Population
      • 8.5.1.4 Growing Prevalence of Chronic Respiratory Diseases across the Globe
    • 8.5.2 Market Restraints
      • 8.5.2.1 High Upfront Cost of Device
      • 8.5.2.2 Side-Effects Associated with Long-Term Usage
    • 8.5.3 Impact Analysis
    • 8.5.4 Market Opportunities
      • 8.5.4.1 Development of Smart CPAP Devices
      • 8.5.4.2 Digitization of Device Training Modules to Promote Adoption

9 Continuous Positive Airway Pressure Market (by End-User)

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
  • 9.3 Nursing Homes
  • 9.4 Elderly Care Centers
  • 9.5 Home-Use

10 Continuous Positive Airway Pressure (CPAP) Market (by Region)

  • 10.1 North America Continuous Positive Airway Pressure (CPAP) Market
    • 10.1.1 Market Size and Forecast
    • 10.1.2 CPAP Shipment (Unit Sold)
    • 10.1.3 Pricing Analysis
    • 10.1.4 North America Prevalence Analysis
    • 10.1.5 North America CPAP Market Competitive Analysis
      • 10.1.5.1 Market Share
      • 10.1.5.2 Key Competitors
      • 10.1.5.3 Unit Shipment and Brand Matrix
    • 10.1.6 North America CPAP Market, by Country
      • 10.1.6.1 U.S.
        • 10.1.6.1.1 U.S. Prevalence Analysis
      • 10.1.6.2 Canada
        • 10.1.6.2.1 Canada Prevalence Analysis
  • 10.2 EU5 Continuous Positive Airway Pressure (CPAP) Market
    • 10.2.1 Market Size and Forecast
    • 10.2.2 CPAP Shipment (Unit Sold)
    • 10.2.3 Pricing Analysis
    • 10.2.4 EU5 Prevalence Analysis
    • 10.2.5 EU5 CPAP Market Competitive Analysis
      • 10.2.5.1 Market Share
      • 10.2.5.2 Key Competitors
      • 10.2.5.3 Unit Shipment and Brand Matrix
    • 10.2.6 EU5 CPAP Market (by Country)
      • 10.2.6.1 Germany
        • 10.2.6.1.1 Germany Prevalence Analysis
      • 10.2.6.2 U.K.
        • 10.2.6.2.1 U.K. Prevalence Analysis
      • 10.2.6.3 France
        • 10.2.6.3.1 France Prevalence Analysis
      • 10.2.6.4 Italy
        • 10.2.6.4.1 Italy Prevalence Analysis
      • 10.2.6.5 Spain
        • 10.2.6.5.1 Spain Prevalence Analysis
  • 10.3 Asia-Pacific Continuous Positive Airway Pressure (CPAP) Market
    • 10.3.1 Market Size and Forecast
    • 10.3.2 CPAP Shipment (Unit Sold)
    • 10.3.3 Pricing Analysis
    • 10.3.4 Asia-Pacific Prevalence Analysis
    • 10.3.5 Asia-Pacific CPAP Market Competitive Analysis
      • 10.3.5.1 Market Share
      • 10.3.5.2 Key Competitors
      • 10.3.5.3 Unit Shipment and Brand Matrix
    • 10.3.6 Asia-Pacific CPAP Market, by Country
      • 10.3.6.1 China
        • 10.3.6.1.1 China Prevalence Analysis
      • 10.3.6.2 India
        • 10.3.6.2.1 India Prevalence Analysis
      • 10.3.6.3 Japan
        • 10.3.6.3.1 Japan Prevalence Analysis
      • 10.3.6.4 South Korea
        • 10.3.6.4.1 South Korea Prevalence Analysis
      • 10.3.6.5 Rest-of-Asia-Pacific
        • 10.3.6.5.1 Rest-of-Asia-Pacific Prevalence Analysis
          • 10.3.6.5.1.1 Bangladesh
          • 10.3.6.5.1.2 Pakistan
          • 10.3.6.5.1.3 Malaysia
          • 10.3.6.5.1.4 Indonesia
  • 10.4 Rest-of-the-World Continuous Positive Airway Pressure (CPAP) Market
    • 10.4.1 Market Size and Forecast
    • 10.4.2 CPAP Shipment (Unit Sold)
    • 10.4.3 Rest-of-the-World CPAP Market (by Region)
      • 10.4.3.1 Europe Excluding EU5
      • 10.4.3.2 MEA
      • 10.4.3.3 Latin America

11 Company Profiles

  • 11.1 APEX MEDICAL CORP.
    • 11.1.1 Company Overview
    • 11.1.2 Role of APEX MEDICAL CORP. in Global Continuous Positive Airway Pressure Market
    • 11.1.3 Recent Developments
    • 11.1.4 SWOT Analysis
  • 11.2 Airon Corporation
    • 11.2.1 Company Overview
    • 11.2.2 Role of Airon Corporation in Global Continuous Positive Airway Pressure Market
    • 11.2.3 Recent Developments
    • 11.2.4 SWOT Analysis
  • 11.3 Asahi Kasei Corporation
    • 11.3.1 Company Overview
    • 11.3.2 Role of Asahi Kasei Corporation in Global Continuous Positive Airway Pressure Market
    • 11.3.3 Financials
    • 11.3.4 SWOT Analysis
  • 11.4 BMC Medical Co., Ltd
    • 11.4.1 Company Overview
    • 11.4.2 Role of BMC Medical Co., Ltd in Global Continuous Positive Airway Pressure Market
    • 11.4.3 Recent Developments
    • 11.4.4 SWOT Analysis
  • 11.5 Dragerwerk AG & Co. KGaA
    • 11.5.1 Company Overview
    • 11.5.2 Role of Dragerwerk AG & Co. KGaA in Global Continuous Positive Airway Pressure Market
    • 11.5.3 Financials
    • 11.5.4 SWOT Analysis
  • 11.6 Fisher & Paykel Healthcare Limited
    • 11.6.1 Company Overview
    • 11.6.2 Role of Fisher & Paykel Healthcare Limited in Global Continuous Positive Airway Pressure Market
    • 11.6.3 Financials
    • 11.6.4 Recent Developments
    • 11.6.5 SWOT Analysis
  • 11.7 General Electric Company
    • 11.7.1 Company Overview
    • 11.7.2 Role of General Electric Company in Global Continuous Positive Airway Pressure Market
    • 11.7.3 Financials
    • 11.7.4 SWOT Analysis
  • 11.8 Getinge AB
    • 11.8.1 Company Overview
    • 11.8.2 Role of Getinge AB in Global Continuous Positive Airway Pressure Market
    • 11.8.3 Financials
    • 11.8.4 SWOT Analysis
  • 11.9 Koninklijke Philips N.V.
    • 11.9.1 Company Overview
    • 11.9.2 Role of Koninklijke Philips N.V. in Global Continuous Positive Airway Pressure Market
    • 11.9.3 Financials
    • 11.9.4 Recent Developments
    • 11.9.5 SWOT Analysis
  • 11.1 Lowenstein Medical GmbH & Co. KG
    • 11.10.1 Company Overview
    • 11.10.2 Role of Lowenstein Medical GmbH & Co. KG in Global Continuous Positive Airway Pressure Market
    • 11.10.3 SWOT Analysis
  • 11.11 Medical Depot, Inc. dba drives DeVilbiss Healthcare LLC
    • 11.11.1 Company Overview
    • 11.11.2 Role of Medical Depot, Inc. in Global Continuous Positive Airway Pressure Market
    • 11.11.3 SWOT Analysis
  • 11.12 Medtronic Plc
    • 11.12.1 Company Overview
    • 11.12.2 Role of Medtronic Plc in Global Continuous Positive Airway Pressure Market
    • 11.12.3 Financials
    • 11.12.4 SWOT Analysis
  • 11.13 ResMed Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Role of ResMed Inc. in Global Continuous Positive Airway Pressure Market
    • 11.13.3 Financials
    • 11.13.4 Recent Developments
    • 11.13.5 SWOT Analysis
  • 11.14 Smiths Group plc (Smiths Medical)
    • 11.14.1 Company Overview
    • 11.14.2 Role of Smiths Group plc in Global Continuous Positive Airway Pressure Market
    • 11.14.3 Financials
    • 11.14.4 SWOT Analysis
  • 11.15 VYAIRE MEDICAL, INC.
    • 11.15.1 Company Overview
    • 11.15.2 Role of VYAIRE MEDICAL, INC. in Global Continuous Positive Airway Pressure Market
    • 11.15.3 SWOT Analysis

List of Tables

  • Table 6.1: Association/Consortium of the Global Continuous Positive Airway Pressure Market
  • Table 6.2: European Commission Medical Device Directives
  • Table 6.3: Federal Agencies of EU Member States
  • Table 6.4: Regulatory Bodies in Asia-Pacific
  • Table 6.5: Global Continuous Positive Airway Pressure Market: Patent Analysis (by Country), January 2017-December 2020

List of Figures

  • Figure 1: Global CPAP Market (by End-User), $Million, 2015-2026
  • Figure 2: Global CPAP Market (by Region), $Million, 2015-2026
  • Figure 3: Key Players CPAP Revenue (Cumulative), 2015-2019
  • Figure 4: Global CPAP Market: Impact Analysis
  • Figure 5: Global CPAP Market Size COVID-19 Impact, 2020-2026
  • Figure 6: Global CPAP Market: Key Developments and Strategies, January 2016-February 2021
  • Figure 2.1: Global CPAP Market Segmentation
  • Figure 3.1: Global CPAP Market: Research Methodology
  • Figure 3.2: Primary Research
  • Figure 3.3: Secondary Research
  • Figure 3.4: Global CPAP Market: Bottom-Up Process 1
  • Figure 3.5: Global CPAP Market: Bottom-Up Process 2
  • Figure 3.6: Data Triangulation
  • Figure 3.7: Total Number of Healthcare Company Profiles
  • Figure 3.8: Forecast, Assumptions and Limitations
  • Figure 4.1: Global CPAP Market Size COVID-19 Impact, 2015-2026
  • Figure 4.2: Global CPAP Market: COVID-19 Impact on Volume (by Key Regions)
  • Figure 4.3: Potential COVID-19 Recovery Scenarios
  • Figure 5.1 Global Prevalence and Incidence (Obstructive Sleep Apnea), 2015-2026
  • Figure 5.2: North America Prevalence and Incidence (Obstructive Sleep Apnea), 2015-2026
  • Figure 5.3: EU5 Prevalence and Incidence (Obstructive Sleep Apnea), 2015-2026
  • Figure 5.4: Asia-Pacific Prevalence and Incidence (Obstructive Sleep Apnea), 2015-2026
  • Figure 5.5: Obstructive Sleep Apnea Prevalence (by Region), 2015-2026
  • Figure 5.6: Obstructive Sleep Apnea Incidence (by Region), 2015-2026
  • Figure 5.7: Obstructive Sleep Apnea CPAP Devices Demand, Million Units, 2015-2026
  • Figure 5.8: Global Prevalence and Incidence (Chronic Obstructive Respiratory Diseases), 2015-2026
  • Figure 5.9: North America Prevalence and Incidence (Chronic Obstructive Respiratory Diseases), 2015-2026
  • Figure 5.10: EU5 Prevalence and Incidence (Chronic Obstructive Respiratory Diseases), 2015-2026
  • Figure 5.11: Asia-Pacific Prevalence and Incidence (Chronic Obstructive Respiratory Diseases), 2015-2026
  • Figure 5.12: Chronic Obstructive Respiratory Diseases Prevalence (by Region), 2015-2026
  • Figure 5.13: Chronic Obstructive Respiratory Diseases Incidence (by Region), 2015-2026
  • Figure 5.14: Obstructive Sleep Apnea CPAP Devices Demand, Million Units, 2015-2026
  • Figure 5.15: Global Prevalence and Incidence (Neuromuscular Disorders), 2015-2026
  • Figure 5.16: North America Prevalence and Incidence (Neuromuscular Disorders), 2015-2026
  • Figure 5.17: EU5 Prevalence and Incidence (Neuromuscular Disorders), 2015-2026
  • Figure 5.18: Asia-Pacific Prevalence and Incidence (Neuromuscular Disorders), 2015-2026
  • Figure 5.19: Neuromuscular Disorders Prevalence (by Region), 2015-2026
  • Figure 5.20: Neuromuscular Disorders Incidence (by Region), 2015-2026
  • Figure 5.21: Neuromuscular Disorders CPAP Devices Demand, Units, 2015-2026
  • Figure 5.22: Global Prevalence and Incidence (COVID-19), January 22, 2020-January 01, 2021
  • Figure 5.23: North America Prevalence and Incidence (COVID-19), January 22, 2020-January 01, 2021
  • Figure 5.24: EU5 Prevalence and Incidence (COVID-19), January 22, 2020-January 01, 2021
  • Figure 5.25: Asia-Pacific Prevalence and Incidence (COVID-19), January 22, 2020-January 01, 2021
  • Figure 5.26: COVID-19 CPAP Devices Demand, Units, 2020-2026
  • Figure 5.27: Asthma Incidence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 5.28: Asthma Incidence (by Region), 2015-2026
  • Figure 5.29: Asthma Prevalence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 5.30: Asthma Prevalence (by Region), 2015-2026
  • Figure 5.31: Pneumoconiosis Incidence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 5.32: Pneumoconiosis Incidence (by Region), 2015-2026
  • Figure 5.33: Pneumoconiosis Prevalence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 5.34: Pneumoconiosis Prevalence (by Region), 2015-2026
  • Figure 5.35: Upper Respiratory Tract Infections Incidence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 5.36: Upper Respiratory Tract Infections Incidence (by Region), 2015-2026
  • Figure 5.37: Upper Respiratory Tract Infections Prevalence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 5.38: Upper Respiratory Tract Infections Prevalence (by Region), 2015-2026
  • Figure 5.39: Lower Respiratory Tract Infections Incidence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 5.40: Lower Respiratory Tract Infections Incidence (by Region), 2015-2026
  • Figure 5.41: Lower Respiratory Tract Infections Prevalence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 5.42: Lower Respiratory Tract Infections Prevalence (by Region), 2015-2026
  • Figure 5.43: Other Conditions CPAP Devices Demand, Units, 2015-2026
  • Figure 6.1: Global Continuous Positive Airway Pressure Market Supply Chain Analysis
  • Figure 6.2: Global CPAP Market: Regulatory Landscape
  • Figure 6.3: EU Regulatory Pathway for Medical Device
  • Figure 6.4: NMPA Regulatory Pathway for Medical Device
  • Figure 6.5: PMDA Regulatory Pathway for Medical Device
  • Figure 6.6: Global Continuous Positive Airway Pressure Market: Patent Analysis (by Quarters), January 2015-December 2020
  • Figure 7.1 Global Market Company Share Analysis (CPAP Mode Ventilator and CPAP), 2019
  • Figure 7.2: Regional Company Market Share (CPAP Mode Ventilators), 2019
  • Figure 7.3: Regional Company Market Share (CPAP), 2019
  • Figure 7.4 Global CPAP Market Growth Share Matrix (2015-2019)
  • Figure 7.5: Share of Key Developments and Strategies, January 2016-February 2021
  • Figure 7.6: New Offerings (by Company), January 2016-Febraury 2021
  • Figure 7.7: Partnerships and Alliances (by Company), January 2016-Febraury 2021
  • Figure 7.8: Partnerships and Alliances (by Company), January 2016-Febraury 2021
  • Figure 8.1: Global CPAP Market Opportunity Assessment, 2015-2026
  • Figure 8.2: Global CPAP Market Size and Growth Potential, $Billion, 2015-2026
  • Figure 8.3: Global Prevalence (Obstructive Sleep Apnea), 2015-2026
  • Figure 8.4: Global Sleep Apnea Prevalence (by Age Group), 2015-and 2019
  • Figure 8.5: Impact Analysis of Drivers of the Continuous Positive Airway Pressure (CPAP) Market
  • Figure 9.1: Global CPAP Market Size (Hospitals and Clinics), $Million, 2015-2026
  • Figure 9.2: Global CPAP Market Size (Nursing Homes), $Million, 2015-2026
  • Figure 9.3: Global CPAP Market Size (Elderly Care Homes), $Million, 2015-2026
  • Figure 9.4: Global CPAP Market Size (Home-Use), $Million, 2015-2026
  • Figure 10.1: Global Positive Airway Pressure Market (by Region), 2020
  • Figure 10.2: North America CPAP Market Size, $Million, 2015-2026
  • Figure 10.3: North America CPAP Market Shipments, Million Units, 2015-2026
  • Figure 10.4: North America CPAP Pricing Analysis, $, 2015-2026
  • Figure 10.5: North America Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.6: North America CPAP Brand Share Analysis, 2019
  • Figure 10.7: North America CPAP Market: Key Competitors
  • Figure 10.8: North America CPAP Market: Company Unit Shipment and Brand Matrix, 2015-2019
  • Figure 10.9: U.S. CPAP Market Size, $Million, 2015-2026
  • Figure 10.10: U.S. Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.11: Canada CPAP Market Size, $Million, 2015-2026
  • Figure 10.12 Canada Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.13: EU5 CPAP Market Size, $Million, 2015-2026
  • Figure 10.14: EU5 CPAP Market Shipments, Million Units, 2015-2026
  • Figure 10.15: EU5 CPAP Pricing Analysis, $, 2015-2026
  • Figure 10.16: EU5 Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.17: EU5 CPAP Brand Share Analysis, 2019
  • Figure 10.18: EU5 CPAP Market: Key Competitors
  • Figure 10.19: EU5 CPAP Market: Company Unit Shipment and Brand Matrix, 2015-2019
  • Figure 10.20: Germany CPAP Market Size, $Million, 2015-2026
  • Figure 10.21: Germany Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.22: U.K. CPAP Market Size, $Million, 2015-2026
  • Figure 10.23: U.K. Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.24: France CPAP Market Size, $Million, 2015-2026
  • Figure 10.25: France Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.26: Italy CPAP Market Size, $Million, 2015-2026
  • Figure 10.27: Italy Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.28: Spain CPAP Market Size, $Million, 2015-2026
  • Figure 10.29: Spain Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.30: Asia-Pacific CPAP Market Size, $Million, 2015-2026
  • Figure 10.31: Asia-Pacific CPAP Market Shipments, Million Units, 2015-2026
  • Figure 10.32: Asia-Pacific CPAP Pricing Analysis, $, 2015-2026
  • Figure 10.33: Asia-Pacific Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.34: Asia-Pacific CPAP Brand Share Analysis, 2019
  • Figure 10.35: Asia-Pacific CPAP Market: Key Competitors
  • Figure 10.36: Asia-Pacific CPAP Market: Company Unit Shipment and Brand Matrix, 2015-2019
  • Figure 10.37: China CPAP Market Size, $Million, 2015-2026
  • Figure 10.38: China Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.39: India CPAP Market Size, $Million, 2015-2026
  • Figure 10.40: India Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.41: Japan CPAP Market Size, $Million, 2015-2026
  • Figure 10.42: Japan Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.43: South Korea CPAP Market Size, $Million, 2015-2026
  • Figure 10.44: South Korea Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.45: Rest of Asia-Pacific CPAP Market Size, $Million, 2015-2026
  • Figure 10.46: Bangladesh Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.47: Pakistan Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.48: Malaysia Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.49: Indonesia Disease Prevalence, Million Cases, 2015-2026
  • Figure 10.50: Rest-of-the-World CPAP Market Size, $Million, 2015-2026
  • Figure 10.51: Rest-of-the-World CPAP Market Shipments, Million Units, 2015-2026
  • Figure 10.52: Europe except EU5 CPAP Market Size, $Million, 2015-2026
  • Figure 10.53: MEA CPAP Market Size, $Million, 2015-2026
  • Figure 10.54: Latin America Market Size, $Million, 2015-2026
  • Figure 11.1: APEX MEDICAL CORP.: Overall Product Portfolio
  • Figure 11.2: APEX MEDICAL CORP.: SWOT Analysis
  • Figure 11.3: Airon Corporation: Overall Product Portfolio
  • Figure 11.4: Airon Corporation.: SWOT Analysis
  • Figure 11.5: Asahi Kasei Corporation: Overall Product Portfolio
  • Figure 11.6: Asahi Kasei Corporation: Overall Revenue, 2017-2019
  • Figure 11.7: Asahi Kasei Corporation: Revenue (by Segment), 2017-2019
  • Figure 11.8: Asahi Kasei Corporation: Revenue (by Region), 2017
  • Figure 11.9: Asahi Kasei Corporation: Revenue (by Region), 2018-2019
  • Figure 11.10: Asahi Kasei Corporation: SWOT Analysis
  • Figure 11.11: BMC Medical Co., Ltd: Overall Product Portfolio
  • Figure 11.12: BMC Medical Co., Ltd: SWOT
  • Figure 11.13: Dragerwerk AG & Co. KGaA: Overall Product Portfolio
  • Figure 11.14: Dragerwerk AG & Co. KGaA: Overall Financials, 2017-2019
  • Figure 11.15: Dragerwerk AG & Co. KGaA: Revenue (by Region), 2017-2019
  • Figure 11.16: Dragerwerk AG & Co. KGaA: SWOT Analysis
  • Figure 11.17: Fisher & Paykel Healthcare Limited: Overall Product Portfolio
  • Figure 11.18: Fisher & Paykel Healthcare Limited: Overall Financials, 2018-2020
  • Figure 11.19: Fisher & Paykel Healthcare Limited.: Revenue (by Segment), 2018-2020
  • Figure 11.20: Fisher & Paykel Healthcare Limited: Revenue (by Region), 2018-2020
  • Figure 11.21: Fisher & Paykel Healthcare Limited: SWOT Analysis
  • Figure 11.22: General Electric Company: Overall Product Portfolio
  • Figure 11.23: General Electric Company: Overall Financials, 2018-2020
  • Figure 11.24: General Electric Company: Revenue (by Segment), 2018-2020
  • Figure 11.25: General Electric Company: Revenue (by Region), 2018-2020
  • Figure 11.26: General Electric Company: SWOT Analysis
  • Figure 11.27: Getinge AB: Overall Product Portfolio
  • Figure 11.28: Getinge AB: Overall Financials, 2018-2020
  • Figure 11.29: Getinge AB: Revenue (by Segment), 2018-2020
  • Figure 11.30: Getinge AB: Revenue (by Region), 2018-2019
  • Figure 11.31: Getinge AB: SWOT Analysis
  • Figure 11.32: Koninklijke Philips N.V.: Overall Product Portfolio
  • Figure 11.33: Koninklijke Philips N.V.: Overall Financials, 2017-2019
  • Figure 11.34: Koninklijke Philips N.V.: Revenue (by Business Segment), 2017-2019
  • Figure 11.35: Koninklijke Philips N.V.: Revenue (by Region), 2017-2019
  • Figure 11.36: Koninklijke Philips N.V.: SWOT Analysis
  • Figure 11.37: Lowenstein Medical GmbH & Co. KG: Overall Product Portfolio
  • Figure 11.38: Lowenstein Medical GmbH & Co. KG: SWOT Analysis
  • Figure 11.39: Medical Depot, Inc.: Overall Product Portfolio
  • Figure 11.40: Medical Depot, Inc.: SWOT Analysis
  • Figure 11.41: Medtronic plc: Overall Product Portfolio
  • Figure 11.42: Medtronic plc: Overall Financials, 2018-2020
  • Figure 11.43: Medtronic plc: Revenue (by Segment), 2018-2020
  • Figure 11.44: Medtronic plc: Revenue (by Region), 2018-2020
  • Figure 11.45: Medtronic plc: SWOT Analysis
  • Figure 11.46: ResMed Inc.: Overall Product Portfolio
  • Figure 11.47: ResMed Inc.: Overall Financials, 2018-2020
  • Figure 11.48: ResMed Inc.: Revenue (by Segment), 2018-2020
  • Figure 11.49: ResMed Inc.: Revenue (by Region), 2018-2020
  • Figure 11.50: ResMed Inc.: SWOT Analysis
  • Figure 11.51: Smiths Group plc: Overall Product Portfolio
  • Figure 11.52: Smiths Group plc: Overall Financials, 2018-2020
  • Figure 11.53: Smiths Group plc: Revenue (by Segment), 2018-2020
  • Figure 11.54: Smiths Group plc: Revenue (by Region), 2018-2020
  • Figure 11.55: Smiths Group plc: Revenue (by Region), 2018
  • Figure 11.56: Smiths Group plc: Revenue (by Region), 2019-2020
  • Figure 11.57: Smiths Group plc: SWOT Analysis
  • Figure 11.58: VYAIRE MEDICAL, INC.: Overall Product Portfolio
  • Figure 11.59: VYAIRE MEDICAL, INC.: SWOT Analysis